Literature DB >> 1610295

Differences in the response of Sprague-Dawley and Lewis rats to bezafibrate: the hypolipidemic effect and the induction of peroxisomal enzymes.

J Pill1, A Völkl, F Hartig, H D Fahimi.   

Abstract

The effects of bezafibrate administered at 10 and 50 mg/kg/day for 7 days to male Sprague-Dawley (SD) and Lewis rats were investigated in order to determine the interrelation between the changes in serum and hepatic lipid contents and activities of selected peroxisomal, microsomal and mitochondrial enzymes in the two rat strains. In both strains, bezafibrate effectively reduced serum and hepatic lipids, increased the liver weight, induced a proliferation of peroxisomes, and selectively elevated the activities of carnitine acetyltransferase and of the enzymes of the peroxisomal beta-oxidation system. Moreover, immunoblotting revealed that the drug specifically enhanced the concentration of only those peroxisomal enzymes involved in fatty acid beta-oxidation. The data obtained demonstrate that although the responses initiated by bezafibrate are qualitatively similar in both strains, they differ in their magnitude in a dose-dependent manner, with the Lewis strain exhibiting a more pronounced response than the SD rats. These results show that dose-dependent strain differences as well as the generally known species differences should be taken into account in pharmacological and toxicological evaluations of fibrates in rodents. Furthermore, generalization and extrapolation from rodent studies should be treated with great caution.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1610295     DOI: 10.1007/bf01973627

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  42 in total

1.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators.

Authors:  I Issemann; S Green
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

Review 2.  Biochemical mechanisms of induction of hepatic peroxisome proliferation.

Authors:  E A Lock; A M Mitchell; C R Elcombe
Journal:  Annu Rev Pharmacol Toxicol       Date:  1989       Impact factor: 13.820

3.  Proliferation of peroxisomes and induction of cytosolic and microsomal epoxide hydrolases in different strains of mice and rats after dietary treatment with clofibrate.

Authors:  B Lundgren; J W DePierre
Journal:  Xenobiotica       Date:  1989-08       Impact factor: 1.908

4.  A microspectrophotometric method for the determination of cytochrome oxidase.

Authors:  S J COOPERSTEIN; A LAZAROW
Journal:  J Biol Chem       Date:  1951-04       Impact factor: 5.157

5.  Change in very low-, low-, and high-density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemia.

Authors:  D Gavish; Y Oschry; M Fainaru; S Eisenberg
Journal:  Eur J Clin Invest       Date:  1986-02       Impact factor: 4.686

6.  Hepatic peroxisomal changes induced by a tetrazole-substituted alkoxyacetophenone in rats and comparison with other species.

Authors:  P I Eacho; P S Foxworthy; W D Johnson; D M Hoover; S L White
Journal:  Toxicol Appl Pharmacol       Date:  1986-05       Impact factor: 4.219

7.  [On the enzymatic method of neutral fat determination in biological matter].

Authors:  F H Schmidt; K von Dahl
Journal:  Z Klin Chem Klin Biochem       Date:  1968-05

8.  Effects of bezafibrate on receptor-mediated and receptor-independent low density lipoprotein catabolism in type II hyperlipoproteinaemic subjects.

Authors:  J M Stewart; C J Packard; A R Lorimer; D E Boag; J Shepherd
Journal:  Atherosclerosis       Date:  1982-09       Impact factor: 5.162

9.  Isolation and characterization of peroxisomes from the liver of normal untreated rats.

Authors:  A Völkl; H D Fahimi
Journal:  Eur J Biochem       Date:  1985-06-03

10.  Structure, composition, physical properties, and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver.

Authors:  F Leighton; L Coloma; C Koenig
Journal:  J Cell Biol       Date:  1975-11       Impact factor: 10.539

View more
  3 in total

1.  Strain-dependent urethral response.

Authors:  Donna J Haworth; Takeya Kitta; Brian Morelli; Douglas W Chew; Naoki Yoshimura; William C de Groat; David A Vorp
Journal:  Neurourol Urodyn       Date:  2011-08-08       Impact factor: 2.696

2.  Relationship between plasma lipids and palmitoyl-CoA hydrolase and synthetase activities with peroxisomal proliferation in rats treated with fibrates.

Authors:  M Alegret; R Ferrando; M Vázquez; T Adzet; M Merlos; J C Laguna
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

3.  Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.

Authors:  Wei Chen; Shiyong Fan; Xinni Xie; Nina Xue; Xueyuan Jin; Lili Wang
Journal:  PLoS One       Date:  2014-04-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.